Skip to main content

Table 1 Clinical parameters of the animals

From: Advantages of prophylactic versus conventionally scheduled heart failure therapy in an experimental model of doxorubicin-induced cardiomyopathy

 

CON (n = 7)

D-CON (n = 7)

PRE (n = 8)

POST (n = 7)

Day 0

Day 74

Day 0

Day 74

Day 0

Day 74

Day 0

Day 74

BW (g)

309.29 ± 5.25^

481.71 ± 14.37+§^#

333.43 ± 20.42

328.29 ± 10.91*

331.38 ± 10.86

342.25 ± 49.7*

339.71 ± 10.04*

311.71 ± 22.85*

tBMI (kg/m2)

157 ± 3.57+§^

248.87 ± 8.74+§^#

194.78 ± 18.392*

189.9 ± 9.71*

187.91 ± 10.62*

189.72 ± 15.98*

206.45 ± 11.16*

190.52 ± 7.88*

 

CON (n = 7)

D-CON + POST (n = 16)

PRE (n = 5–8)

Day 0

Day 7

Day 39

Day 0

Day 7

Day 39

Day 0

Day 7

Day 39

SBP (mmHg)

123.31 ± 3.05§

134.51 ± 7.85§

132.77 ± 8.11

132.61 ± 3.27§

136.11 ± 2.47§

145.91 ± 5.54§#

149.73 ± 4.98*+

112.63 ± 4.3*+#

115.44 ± 5.19+#

DBP (mmHg)

92.23 ± 2.49§

104.91 ± 7.35§#

103.34 ± 6.34

102.41 ± 3.23§

103.64 ± 3.01§

110.34 ± 4.39§

116.75 ± 7.06*+

83.3 ± 3.79*+#

85.24 ± 5.77+#

HR (1/min)

418.31 ± 7.27§

419.2 ± 13.05§

405.51 ± 11.18

430.86 ± 11.73

435.75 ± 12.98§

464.06 ± 19.36*§

451.25 ± 11.81*

380.33 ± 10.41*+#

347.24 ± 6.59*+#

  1. BW body weight, DBP diastolic blood pressure, HR heart rate, SBP systolic blood pressure, tBMI body mass indexed for tibia length, n number of animals per group (5 measurements per animal, except for single body weight and tBMI measurements)
  2. * p ≤ 0.05 vs. CON; + p ≤ 0.05 vs. D-CON/D-CON + POST; § p ≤ 0.05 vs. PRE; ^ p ≤ 0.05 vs. POST; # p ≤ 0.05 vs. day 0